European Healthtech startup funding raised during Q4 2015.
In Q4 2015, 80 European Healthtech companies raised a combined €664M across 80 funding rounds, up 123.5% versus Q4 2014. UK led by capital raised, and Caixa Capital Risc was the most active investor. Data as of 23 Aug 2026.
3 exits · €196M disclosed.
| €35M |
| NightstaRx | Series B | Nov 2015 | €32M |
| PREP Biopharm | Series A | Nov 2015 | €29M |
| Kesios Therapeutics | Series A | Dec 2015 | €27M |
| EIMindA | Series C | Nov 2015 | €25M |
| ElMindA | Series C | Nov 2015 | €25M |
| Minoryx Therapeutics | Series A | Oct 2015 | €19M |
| Doctolib | Series B | Oct 2015 | €18M |
| Euroscreen | Series B | Oct 2015 | €16M |
| GamaMabs Pharma | Series B | Dec 2015 | €15M |
| Sophia Genetics | Series C | Dec 2015 | €14M |
| Gamida Cell | Growth/Late | Oct 2015 | €13M |
